Mast cell leukemia differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Mast cell leukemia}} | {{Mast cell leukemia}} | ||
{{CMG}};{{AE}} {{NM}} | {{CMG}};{{AE}} {{NM}}, {{S.G.}} | ||
==Overview== | ==Overview== | ||
[[Mast cell]] leukemia must be differentiated from other [[Disease|diseases]] such as [[systemic mastocytosis]], [[myeloid leukemia|myelomastocytic leukemia]], [[hairy cell leukemia]], [[Hyperplasia|reactive mast cell hyperplasia]], [[B-cell lymphoma|monocytoid B-cell lymphoma]], and [[T-cell leukemia|peripheral T-cell leukemia]]. | [[Mast cell]] leukemia must be differentiated from other [[Disease|diseases]] such as [[systemic mastocytosis]], [[myeloid leukemia|myelomastocytic leukemia]], [[hairy cell leukemia]], [[Hyperplasia|reactive mast cell hyperplasia]], [[B-cell lymphoma|monocytoid B-cell lymphoma]], and [[T-cell leukemia|peripheral T-cell leukemia]]. | ||
Revision as of 12:19, 22 October 2018
|
Mast cell leukemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mast cell leukemia differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Mast cell leukemia differential diagnosis |
|
Risk calculators and risk factors for Mast cell leukemia differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2], Sogand Goudarzi, MD [3]
Overview
Mast cell leukemia must be differentiated from other diseases such as systemic mastocytosis, myelomastocytic leukemia, hairy cell leukemia, reactive mast cell hyperplasia, monocytoid B-cell lymphoma, and peripheral T-cell leukemia.
Mast cell leukemia differential diagnosis
Mast cell leukemia must be differentiated from other diseases such as:[1][2]
- Systemic mastocytosis
- Myelomastocytic leukemia
- Peripheral T-cell leukemia
- Reactive mast cell hyperplasia
- Hairy cell leukemia
- Monocytoid B-cell lymphoma
- Fibroblast proliferation
References
- ↑ Valent, P.; Sotlar, K.; Sperr, W. R.; Escribano, L.; Yavuz, S.; Reiter, A.; George, T. I.; Kluin-Nelemans, H. C.; Hermine, O.; Butterfield, J. H.; Hagglund, H.; Ustun, C.; Hornick, J. L.; Triggiani, M.; Radia, D.; Akin, C.; Hartmann, K.; Gotlib, J.; Schwartz, L. B.; Verstovsek, S.; Orfao, A.; Metcalfe, D. D.; Arock, M.; Horny, H.- P. (2014). "Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal". Annals of Oncology. 25 (9): 1691–1700. doi:10.1093/annonc/mdu047. ISSN 0923-7534.
- ↑ Horvai AE, Link TM. Bone and Soft Tissue Pathology. Elsevier Health Sciences (2012). http://books.google.com?id=p2DV6VWdXx8C. Accessed on November 30, 2015.